MassDevice1d
Johnson & Johnson reportedly wants to sell its Cerenovus stroke business for $1B
Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...
Joint Replacement Devices Market to Hit USD 31.09 Billion by 2030 with 4.8% CAGR | MarketsandMarkets
The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 ...
Le Lézard1d
Joint Replacement Devices Market to Hit USD 31.09 Billion by 2030 with 4.8% CAGR | MarketsandMarketstm
The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 billion in 2024 and an impressive US$31.09 billion by ...
MassDevice1d
Johnson & Johnson MedTech launches catheter system for stroke
Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched the CereGlide 92 catheter system for treating acute ...
Why Johnson & Johnson (JNJ) is the Best Medical Device Stock to Buy
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
J&J puts stroke care unit up for sale, FT reports
Johnson & Johnson is putting its stroke care business up for sale as the company aims to reorganize and rebuild its medtech unit, the ...
J&J puts its stroke care business up for sale: report
Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Times reported on Tuesday, citing people familiar with the matter.